Top

Trials

Published in:

Open Access 01-12-2022 | Antidepressant Drugs | Study protocol

A cluster-randomized trial of a complex intervention to encourage deprescribing antidepressants in nursing home residents with dementia: a study protocol

Authors: Pernille Hølmkjær, Anne Holm, Gritt Overbeck, Maarten Pieter Rozing

Published in: Trials | Issue 1/2022

Abstract

Background

The effectiveness of psychotropic medication on behavioral and psychological symptoms of dementia (BPSD) is limited, while associated with a higher risk of adverse events. Non-pharmacological treatment of BPSD is advocated as treatment of first choice. However, many general practitioners (GPs) find it difficult to initiate deprescribing, and when attempting to discontinue psychotropic medication in nursing home residents, they face many barriers. Therefore, we hypothesize that an intervention aimed at improving communication with and involvement of nursing home staff, relatives, and patients by GPs can optimize the pharmacological treatment of BPSD. The aim is to reduce the use of antidepressants in nursing home residents with dementia without increasing morbidity or mortality.

Objective

The primary outcome is reduction of antidepressant. Secondary outcomes include difference in use of other psychotropic medication, mortality, morbidity, and severity of BPSD.

Method

The study is a cluster-randomized controlled trial based in general practices in Denmark. We aim to include 22 practices, each of which will recruit up to 15 patients with dementia living in nursing homes. The intervention period is 3 months, and the total study period is 1 year. Randomization is 1:1 to intervention and control group by computer algorithm. Both groups receive education on BPSD and its evidence-based treatment. The intervention includes three tailored components; (1) teaching material and training to be used by the GP to educate nursing home staff on BPSD, (2) a pre-visit reflection tool to encourage nursing home staff to evaluate symptoms and reflect on relatives involvement in the discontinuation process; and (3) a dialog tool to facilitate shared decision making on optimization of BPSD treatment during the visits at the nursing home. The control group includes enhanced care as usual. The primary and secondary outcomes will be assessed at the end of the study period. A process evaluation will be conducted to assess the implementability.

Discussion

We anticipate that the intervention will optimize the treatment of BPSD with antidepressants for nursing homes residents and enhance compliance with reduction of medication. The process evaluation should provide insights into the barriers and facilitators to changing the current practice of deprescribing.

Trial registration

Clinicaltrials.gov NCT04985305. Registered on 30 July 2021.

Available only for authorised users

Demens Vf. Forekomst af demens i Danmark. 2018. https://videnscenterfordemens.dk/da/forekomst-af-demens-i-danmark. Accessed 16 Jul 2021.

Selbaek G, Engedal K, Benth J, Bergh S. The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period. Int Psychogeriatr. 2014;26(1):81–91. https://doi.org/10.1017/s1041610213001609.CrossRefPubMed

Kessing LV, Harhoff M, Andersen PK. Treatment with antidepressants in patients with dementia--a nationwide register-based study. Int Psychogeriatr. 2007;19(5):902–13. https://doi.org/10.1017/s1041610206004376.CrossRefPubMed

Lundby C, Jensen J, Larsen SP, Hoffmann H, Pottegård A, Reilev M. Use of medication among nursing home residents: a Danish drug utilisation study. Age Ageing. 2020;49(5):814–20. https://doi.org/10.1093/ageing/afaa029.CrossRefPubMed

Gourdon M, Petit L, Delpierre S, Sebbagh-Eczet M, Estrada J, Marquis C, et al. Overuse of antidepressants in older outpatients with Alzheimer's disease and associated disorders: an observational study. Geriatr Psychol Neuropsychiatr Vieil. 2021. https://doi.org/10.1684/pnv.2021.0934.

Grill P, Marwick C, De Souza N, Burton JK, Hughes C, Guthrie B. The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes. Age Ageing. 2021;50(1):183–9. https://doi.org/10.1093/ageing/afaa122.CrossRefPubMed

Gerlach LB, Fashaw S, Strominger J, Ogarek J, Zullo AR, Daiello LA, et al. Trends in antipsychotic prescribing among long-term care residents receiving hospice care. J Am Geriatr Soc. 2021. https://doi.org/10.1111/jgs.17172.

Izza MAD, Lunt E, Gordon AL, Gladman JRF, Armstrong S, Logan P. Polypharmacy, benzodiazepines, and antidepressants, but not antipsychotics, are associated with increased falls risk in UK care home residents: a prospective multi-centre study. Eur Geriatr Med. 2020;11(6):1043–50. https://doi.org/10.1007/s41999-020-00376-1.CrossRefPubMedPubMedCentral

Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, Schneeweiss S. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ. 2011;183(7):E411–9. https://doi.org/10.1503/cmaj.101406.CrossRefPubMedPubMedCentral

10.

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):403–11. https://doi.org/10.1016/s0140-6736(11)60830-1.CrossRefPubMed

11.

Zakarias JK, Nørgaard A, Jensen-Dahm C, Gasse C, Laursen TM, Palm H, et al. Risk of hospitalization and hip fracture associated with psychotropic polypharmacy in patients with dementia: a nationwide register-based study. Int J Geriatr Psychiatry. 2021. https://doi.org/10.1002/gps.5587.

12.

Lapeyre-Mestre M. A review of adverse outcomes associated with psychoactive drug use in nursing home residents with dementia. Drugs Aging. 2016;33(12):865–88. https://doi.org/10.1007/s40266-016-0414-x.CrossRefPubMed

13.

Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry. 2015;72(5):438–45. https://doi.org/10.1001/jamapsychiatry.2014.3018.CrossRefPubMedPubMedCentral

14.

Borda MG, Jaramillo-Jimenez A, Oesterhus R, Santacruz JM, Tovar-Rios DA, Soennesyn H, et al. Benzodiazepines and antidepressants: effects on cognitive and functional decline in Alzheimer's disease and Lewy body dementia. Int J Geriatr Psychiatry. 2021;36(6):917–25. https://doi.org/10.1002/gps.5494.CrossRefPubMed

15.

Hsu TW, Stubbs B, Liang CS, Chen TY, Yeh TC, Pan CC, et al. Efficacy of serotonergic antidepressant treatment for the neuropsychiatric symptoms and agitation in dementia: a systematic review and meta-analysis. Ageing Res Rev. 2021;69:101362. https://doi.org/10.1016/j.arr.2021.101362.CrossRefPubMed

16.

Tarvainen A, Hartikainen S, Taipale H, Tanskanen A, Koponen M, Tolppanen AM. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease. Int J Geriatr Psychiatry. 2021;36(7):1075–84. https://doi.org/10.1002/gps.5505.CrossRefPubMed

17.

Sundhedsstyrelsen NKRN. Forebyggelse og behandling af adfærdsmæssige og psykiske symptomer hos personer med demens. https://www.sst.dk/da/udgivelser/2019/nkr-forebyggelse-og-behandling-af-adfaerdsmaessige-og-psykiske-symptomer-hos-personer-med-demens. Accessed Accessed 16 Jul 2021.

18.

Wiggin DA, Timmons S, Rukundo A, Walsh KA. Improving the appropriateness of psychotropic prescribing for nursing home residents with dementia: an overview of reviews. Aging Ment Health. 2021;1–8. https://doi.org/10.1080/13607863.2021.1922601.

19.

Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011;11:16. https://doi.org/10.1186/1471-2318-11-16.CrossRefPubMedPubMedCentral

20.

Smeets CHW, Smalbrugge M, Koopmans R, Nelissen-Vrancken M, van der Spek K, Teerenstra S, et al. Can the PROPER intervention reduce psychotropic drug prescription in nursing home residents with dementia? Results of a cluster-randomized controlled trial. Int Psychogeriatr. 2020:1–10. https://doi.org/10.1017/s1041610220000629.

21.

Moth AE, Hølmkjær P, Holm A, Rozing MP, Overbeck G. What Makes Deprescription of psychotropic drugs in nursing home residents with dementia so challenging? A qualitative systematic review of barriers and facilitators. Drugs Aging. 2021. https://doi.org/10.1007/s40266-021-00875-1.

22.

Sundhedsstyrelsen. Puljeopslag: Ansøgning om deltagelse i demensrejseholdsforløb med fokus på nedbringelse af antipsykotisk medicin 2020.

23.

Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. https://doi.org/10.1136/bmj.a1655.CrossRefPubMedPubMedCentral

24.

Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. Bmj. 2013;346:e7586. https://doi.org/10.1136/bmj.e7586.CrossRefPubMedPubMedCentral

25.

Zakarias JK, Jensen-Dahm C, Nørgaard A, Stevnsborg L, Gasse C, Andersen BG, et al. Geographical variation in antipsychotic drug use in elderly patients with dementia: a nationwide study. J Alzheimers Dis. 2016;54(3):1183–92. https://doi.org/10.3233/jad-160485.CrossRefPubMed

26.

(PLO) Plo. Opsøgende hjemmebesøg (overenskomst). 2017. https://www.laeger.dk/opsoegende-hjemmebesoeg-overenskomst. Accessed 1 Jul 2021.

27.

(DSAM) DSfAM. Den ældre patient - Opsøgende hjemmebesøg. 2012. https://vejledninger.dsam.dk/aeldre/?mode=visKapitel&vid=14&cid=438&gotoChapter=440&gotoElement=0. Accessed 1 Jul 2021.

28.

Ældreministeriet S-o. Plejehjemsoversigten. 2021. https://plejehjemsoversigten.dk/. Accessed Accessed 29 Jul 2021.

29.

(VIVE) Dnf-oafv. Normeringer på danske plejecentre. 2019.

30.

Gaugler JE, Yu F, Davila HW, Shippee T. Alzheimer's disease and nursing homes. Health Aff (Millwood). 2014;33(4):650–7. https://doi.org/10.1377/hlthaff.2013.1268.CrossRefPubMedPubMedCentral

31.

Xu S, Jin X, Liu C, Jin Y, Xu Y, Chen L, et al. Investigating the prevalence of dementia and its associated risk factors in a Chinese nursing home. J Clin Neurol. 2017;13(1):10–4. https://doi.org/10.3988/jcn.2017.13.1.10.CrossRefPubMed

32.

Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–14. https://doi.org/10.1212/wnl.44.12.2308.CrossRefPubMed

33.

Wood S, Cummings JL, Hsu MA, Barclay T, Wheatley MV, Yarema KT, et al. The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry. 2000;8(1):75–83. https://doi.org/10.1097/00019442-200002000-00010.CrossRefPubMed

34.

May CR, Cummings A, Girling M, Bracher M, Mair FS, May CM, et al. Using Normalization Process Theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review. Implement Sci. 2018;13(1):80. https://doi.org/10.1186/s13012-018-0758-1.CrossRefPubMedPubMedCentral

35.

Health TDMo. Legal Information on §42 d in The Danish Health Law. https://www.retsinformation.dk/eli/lta/2019/903. Accessed 16 Jul 2021.

Title: A cluster-randomized trial of a complex intervention to encourage deprescribing antidepressants in nursing home residents with dementia: a study protocol
Authors: Pernille Hølmkjær
Anne Holm
Gritt Overbeck
Maarten Pieter Rozing
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Antidepressant Drugs
Care
Dementia
Dementia
Antidepressant Drugs
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06368-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A cluster-randomized trial of a complex intervention to encourage deprescribing antidepressants in nursing home residents with dementia: a study protocol

Abstract

Background

Objective

Method

Discussion

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Method

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2022

Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial

Evaluating a couple communication skills training (CCST) intervention for advanced cancer: study protocol for a randomized controlled trial

DUbbing Language-therapy CINEma-based in Aphasia post-Stroke (DULCINEA): study protocol for a randomized crossover pilot trial

Comparing two advance care planning conversation activities to motivate advance directive completion in underserved communities across the USA: The Project Talk Trial study protocol for a cluster, randomized controlled trial

Measuring aniseikonia and investigating neuroplasticity and image factors in amblyopia (MAGNIFY): study protocol for a randomised clinical trial

E-HEalth treatment in Long-term Dialysis (E-HELD): study protocol for a multicenter randomized controlled trial evaluating personalized Internet-based cognitive-behavioral therapy in dialysis patients